CovidChloroV1, Main, Corpus, bibRecord, 000458

Azithromycin, a questionable treatment for COVID-19.

Identifieur interne : 000458 ( Main/Corpus ); précédent : 000457; suivant : 000459

Azithromycin, a questionable treatment for COVID-19.

Auteurs : O. Belfaqeeh ; R N Janapala ; J. Patel ; A. Alhashmi ; A. Pourmand

Source :

International journal of antimicrobial agents [ 1872-7913 ] ; 2021.

RBID : pubmed:33476733

English descriptors

KwdEn :
- Azithromycin (therapeutic use), COVID-19 (drug therapy), Drug Combinations (MeSH), Drug Therapy, Combination (MeSH), Humans (MeSH), Hydroxychloroquine (therapeutic use), Lopinavir (therapeutic use), Methylprednisolone (therapeutic use), Ritonavir (therapeutic use), SARS-CoV-2 (drug effects).
MESH :
- chemical , therapeutic use : Azithromycin, Hydroxychloroquine, Lopinavir, Methylprednisolone, Ritonavir.
- drug effects : SARS-CoV-2.
- drug therapy : COVID-19.
- chemical : Drug Combinations, Drug Therapy, Combination, Humans.

DOI: 10.1016/j.ijantimicag.2021.106280
PubMed: 33476733
PubMed Central: PMC7817454

Links to Exploration step

pubmed:33476733

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Azithromycin, a questionable treatment for COVID-19.</title>
<author><name sortKey="Belfaqeeh, O" sort="Belfaqeeh, O" uniqKey="Belfaqeeh O" first="O" last="Belfaqeeh">O. Belfaqeeh</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA. Electronic address: Obelfaqeeh@seha.ae.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Janapala, R N" sort="Janapala, R N" uniqKey="Janapala R" first="R N" last="Janapala">R N Janapala</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Patel, J" sort="Patel, J" uniqKey="Patel J" first="J" last="Patel">J. Patel</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alhashmi, A" sort="Alhashmi, A" uniqKey="Alhashmi A" first="A" last="Alhashmi">A. Alhashmi</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pourmand, A" sort="Pourmand, A" uniqKey="Pourmand A" first="A" last="Pourmand">A. Pourmand</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2021">2021</date>
<idno type="RBID">pubmed:33476733</idno>
<idno type="pmid">33476733</idno>
<idno type="doi">10.1016/j.ijantimicag.2021.106280</idno>
<idno type="pmc">PMC7817454</idno>
<idno type="wicri:Area/Main/Corpus">000458</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000458</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Azithromycin, a questionable treatment for COVID-19.</title>
<author><name sortKey="Belfaqeeh, O" sort="Belfaqeeh, O" uniqKey="Belfaqeeh O" first="O" last="Belfaqeeh">O. Belfaqeeh</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA. Electronic address: Obelfaqeeh@seha.ae.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Janapala, R N" sort="Janapala, R N" uniqKey="Janapala R" first="R N" last="Janapala">R N Janapala</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Patel, J" sort="Patel, J" uniqKey="Patel J" first="J" last="Patel">J. Patel</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Alhashmi, A" sort="Alhashmi, A" uniqKey="Alhashmi A" first="A" last="Alhashmi">A. Alhashmi</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pourmand, A" sort="Pourmand, A" uniqKey="Pourmand A" first="A" last="Pourmand">A. Pourmand</name>
<affiliation><nlm:affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">International journal of antimicrobial agents</title>
<idno type="eISSN">1872-7913</idno>
<imprint><date when="2021" type="published">2021</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (therapeutic use)</term>
<term>COVID-19 (drug therapy)</term>
<term>Drug Combinations (MeSH)</term>
<term>Drug Therapy, Combination (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Hydroxychloroquine (therapeutic use)</term>
<term>Lopinavir (therapeutic use)</term>
<term>Methylprednisolone (therapeutic use)</term>
<term>Ritonavir (therapeutic use)</term>
<term>SARS-CoV-2 (drug effects)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Azithromycin</term>
<term>Hydroxychloroquine</term>
<term>Lopinavir</term>
<term>Methylprednisolone</term>
<term>Ritonavir</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS-CoV-2</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>COVID-19</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Drug Combinations</term>
<term>Drug Therapy, Combination</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33476733</PMID>
<DateCompleted><Year>2021</Year>
<Month>03</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised><Year>2021</Year>
<Month>03</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7913</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>57</Volume>
<Issue>3</Issue>
<PubDate><Year>2021</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>International journal of antimicrobial agents</Title>
<ISOAbbreviation>Int J Antimicrob Agents</ISOAbbreviation>
</Journal>
<ArticleTitle>Azithromycin, a questionable treatment for COVID-19.</ArticleTitle>
<Pagination><MedlinePgn>106280</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0924-8579(21)00005-4</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijantimicag.2021.106280</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Belfaqeeh</LastName>
<ForeName>O</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA. Electronic address: Obelfaqeeh@seha.ae.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Janapala</LastName>
<ForeName>R N</ForeName>
<Initials>RN</Initials>
<AffiliationInfo><Affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Patel</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Alhashmi</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pourmand</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>International Medicine Program, George Washington University School of Medicine and Health Sciences, Washington DC, USA.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2021</Year>
<Month>01</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Int J Antimicrob Agents</MedlineTA>
<NlmUniqueID>9111860</NlmUniqueID>
<ISSNLinking>0924-8579</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004338">Drug Combinations</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C558899">lopinavir-ritonavir drug combination</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>2494G1JF75</RegistryNumber>
<NameOfSubstance UI="D061466">Lopinavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber>
<NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>83905-01-5</RegistryNumber>
<NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>O3J8G9O825</RegistryNumber>
<NameOfSubstance UI="D019438">Ritonavir</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>X4W7ZR7023</RegistryNumber>
<NameOfSubstance UI="D008775">Methylprednisolone</NameOfSubstance>
</Chemical>
</ChemicalList>
<SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Int J Antimicrob Agents. 2021 Mar;57(3):106279</RefSource>
<PMID Version="1">33476734</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004338" MajorTopicYN="N">Drug Combinations</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004359" MajorTopicYN="N">Drug Therapy, Combination</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D061466" MajorTopicYN="N">Lopinavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008775" MajorTopicYN="N">Methylprednisolone</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019438" MajorTopicYN="N">Ritonavir</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>11</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>11</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2021</Year>
<Month>1</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2021</Year>
<Month>3</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2021</Year>
<Month>1</Month>
<Day>21</Day>
<Hour>20</Hour>
<Minute>11</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33476733</ArticleId>
<ArticleId IdType="pii">S0924-8579(21)00005-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.ijantimicag.2021.106280</ArticleId>
<ArticleId IdType="pmc">PMC7817454</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000458 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000458 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:33476733
   |texte=   Azithromycin, a questionable treatment for COVID-19.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:33476733" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Azithromycin, a questionable treatment for COVID-19.

Azithromycin, a questionable treatment for COVID-19.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki